| Name |
|---|
MDRV Genemuscular dystrophy, with rimmed vacuoles |
MLIP Genemuscular LMNA-interacting protein Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. [provided by Alliance of Genome Resources, Mar 2025] |
LGMD1H Genelimb girdle muscular dystrophy 1H (autosomal dominant) |
LGMD1G Genelimb girdle muscular dystrophy 1G (autosomal dominant) |
MDC1B GeneMuscular dystrophy, congenital, 1B |
FSHMD1A Genefacioscapulohumeral muscular dystrophy 1A Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary disease of muscle. Patients with FSHD have a chromosomal rearrangement within the subtelomeric region of chromosome 4 (4q35). This region is composed mainly of a polymorphic repeat structure consisting of 3.3 kb repeat units, designated D4Z4. The number of repeat units varies from 10 to more than 100 in the population, however, in FSHD patients only 1-10 repeat units is observed because of a deletion of an integral number of these units. FSHD is caused by an epigenetic mechanism involving the contraction of a subtelomeric macrosatellite repeat, which results in marked hypomethylation of the contracted D4Z4 allele. It is likely not the structure, but the deregulation of transcription of one or more genes as a result of repeat-contraction-mediated chromatin alterations, that causes FSHD. [provided by RefSeq, Sep 2011] |
FSHMD1B Genefacioscapulohumeral muscular dystrophy 1B |
SMAR GeneSpinal muscular atrophy, chronic distal, autosomal recessive |
SMAL Genespinal muscular atrophy, congenital nonprogressive, of lower limbs |
SCA18 Genespinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy) |
MDCMP Genemuscular dystrophy, congenital, merosin-positive |
SMAJ GeneSpinal muscular atrophy, Jokela type |
BFIS1 Genebenign familial infantile convulsions |
NYS5 GeneNystagmus 5, infantile periodic alternating |
CLN6 Geneceroid-lipofuscinosis, neuronal 6, late infantile, variant This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008] |
BFIS4 GeneConvulsions, benign familial infantile, 4 |
PKDTS Genepolycystic kidney disease, infantile severe, with tuberous sclerosis |
BFIC2 GeneBenign familial infantile convulsions-2 |
EIM GeneInfantile myoclonic epilepsy |
GLC3B Geneglaucoma 3, primary infantile, B |
IHPS2 GenePyloric stenosis, infantile hypertrophic, 2 |
CMS1A1 Genemyasthenia gravis, familial infantile, 1 |
IHPS5 GenePyloric stenosis, infantile hypertrophic, 5 |
IHPS4 GenePyloric stenosis, infantile hypertrophic, 4 |
IHPS3 GenePyloric stenosis, infantile hypertrophic, 3 |